Blood Collection Devices Market Expected to Cross a Valuation of US$ 11 Billion by 2022- 2032
The blood collection devices market is poised to attain a CAGR of 6.3% during the forecast period 2022-2032, as per the blood collection devices market analysis by Future Market Insights (FMI).
The rising number of accidents and trauma cases, the
emergence of liquid biopsy tests, and the demand for blood donations and blood
components are some pivotal factors driving the demand for blood
collection devices and propelling the market.
A major factor shaping the demand for blood
collection devices is the rising prevalence of infectious diseases
such as hepatitis B (HBV), hepatitis C (HCV), human immunodeficiency virus
(HIV), malaria, syphilis, and brucellosis.
Click to get the
Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-14249
A greater emphasis and adherence to health checkups and
awareness of disease conditions via blood collection/blood drawing device ensued
from burden of various chronic diseases, prevalence of lifestyle diseases
around the globe, especially in emerging countries.
As blood tests are the primary mode of diagnosing these
diseases, this will flourish the blood collection devices market growth and
act as a significant contributor to the adoption of blood collection
devices.
The global outbreak of COVID-19 is expected to have a
positive impact on the blood collection devices adoption trends since
blood testing involves the testing of various blood samples, which aids in the
diagnosis of infectious diseases such as COVID-19.
Testing is still an important step in combating the COVID-19
pandemic. As the number of COVID-19 cases grows worldwide, governments around
the world are looking into the possibility of allowing private laboratories to
ramp up blood testing and in turn booming the market.
Taking into account all the aforesaid factors, the blood
collection devices market is forecasted to reach US$ 8 Bn by 2026.
Key Takeaways:
- Capital investments
in automated blood collection using apheresis devices
range between USD 45,000 and USD 55,000.
- By
end user, the segment of hospitals, ASCs and nursing homes held a
major blood collection devices market share in the recent
past.
- North
America has been at the forefront of the sales of blood collection
devices owing to presence of key players in the region.
- The
anticipated blood collection devices market size is US$
11 Bn by 2032.
- By
method, the segment of manual blood collection is
expected to dominate the global market in the coming years.
- By
application, the diagnostics segment is anticipated to be at the forefront
of the blood collection market.
"Whole blood sample storage and shipping present
significant challenges and costs as it must be used immediately after
collection or stored & kept under strict temperature and environmental conditions
for analysis or other applications. If blood samples are not refrigerated or
frozen, their properties begin to change within hours of collection and this is
a prime challenge that the blood collection devices market is confronted
with." points an FMI researcher.
Competitive Landscape:
A few of the major players are Smiths Medical (US),
Dickinson and Company (US), Terumo BCT (US), Retractable Technologies (US),
Fresenius Kabi AG (Germany), Becton, Grifols S.A.(Spain), Terumo BCT (US),
Haematonics (US), Greiner Holding (Austria), Quest Diagnostics (US), Nipro
Medical Corporation (Japan), SARSTEDT AG & Co. (Germany), Macopharma
(France), and Cardinal Health (US).
To increase their share, major corporations are pursuing a
variety of organic and inorganic strategies such as collaborations, new product
development, acquisitions, and regional expansion.
Key Developments:
- Greiner
Bio-One International GmbH acquired VacutteEspana and Vacuette Portula.
This acquisition was made to strengthen Greiner Bio-One International's
distribution and commercial network for blood collection products.
- Drawbridge
Health, a person diagnostic testing startup developing proprietary
technology designed to integrate blood draw, collection, and sample
stabilization into a single device, has been announced by GE Ventures.
Healthcare providers will be able to provide a better patient experience
by utilizing the new blood sample collection devices and
technology.
This integrated technology is also being developed to
support room temperature shipping and streamlined downstream processing,
ensuring consistent and accurate results.
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government,
investors, and associated audiences in the healthcare sector to
identify and accentuate vital aspects applicable to product strategy,
regulatory landscape, technology evolution, and other crucial issues to achieve
sustainable success. Our unique approach to gathering market intelligence
equips you in devising innovation-driven trajectories for your business. Know
more about our sector coverage here
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market
intelligence and consulting services, serving clients in over 150 countries.
FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and
India. FMI's latest market research reports and industry analysis
help businesses navigate challenges and make critical decisions with confidence
and clarity amidst breakneck competition. Our customized and syndicated
market research reports deliver actionable insights that drive sustainable
growth. A team of expert-led analysts at FMI continuously tracks emerging
trends and events in a broad range of industries to ensure that our clients
prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Comments
Post a Comment